Capping gold nanoparticles with albumin to improve their biomedical properties

References

• Danhier F. To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release. 2016;244:108–121. doi:10.1016/j.jconrel.2016.11.01527871992
   PubMed Web of Science ®Google Scholar
• Chen Q, Liu Z. Albumin carriers for cancer theranostics: a conventional platform with new promise. Adv Mater. 2016;28:10557–10566. doi:10.1002/adma.v28.4727111654
   PubMed Web of Science ®Google Scholar
• Mariam J, Sivakami S, Dongre PM. Elucidation of structural and functional properties of albumin bound to gold nanoparticles. J Biomol Struct Dyn. 2017;35:368–379. doi:10.1080/07391102.2016.114422326821333
   PubMed Web of Science ®Google Scholar
• Eustis S, El-Sayed MA. Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem Soc Rev. 2006;35:209–217. doi:10.1039/B514191E16505915
   PubMed Web of Science ®Google Scholar
• Alfranca, G,Artiga A, Stepien G, et al. Gold nanoprism – nanorod face off : comparing the heating efficiency, cellular internalization and thermoablation capacity. Nanomedicine (Lond.). 2016;11:2903–2916. doi:10.2217/nnm-2016-023327785974
   PubMed Web of Science ®Google Scholar
• AL-Jawad SMH, Taha AA, Al-Halbosiy MMF, AL-Barram LFA. Synthesis and characterization of small-sized gold nanoparticles coated by bovine serum albumin (BSA) for cancer photothermal therapy. Photodiagnosis Photodyn Ther. 2018;21:201–210. doi:10.1016/j.pdpdt.2017.12.00429223737
   PubMed Web of Science ®Google Scholar
• Uppal A, Bose B. Synthesis, stability, and in vitro oral cancer cell toxicity of human serum albumin stabilised gold nanoflowers. IEE. 2018. doi:10.1049/iet-nbt.2017.0002
   Google Scholar
• Kuo W-S, Chang Y-T, Cho K-C, et al. Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy. Biomaterials. 2012;33:3270–3278. doi:10.1016/j.biomaterials.2012.01.03522289264
   PubMed Web of Science ®Google Scholar
• Santos NC, Domingues MM, Felício MR, Gonçalves S, Carvalho PM. Application of light scattering techniques to nanoparticle characterization and development. Front Chem. 2018;6:1–17.29441345
   PubMed Web of Science ®Google Scholar
• Peralta DV, Heidari Z, Dash S, Tarr MA. Hybrid paclitaxel and gold nanorod-loaded human serum albumin nanoparticles for simultaneous chemotherapeutic and photothermal therapy on 4T1 breast cancer cells. ACS Appl Mater Interfaces. 2015;7:7101–7111. doi:10.1021/acsami.5b0085825768122
   PubMedGoogle Scholar
• Kelkar SS, Reineke TM. Theranostics : combining imaging and therapy. Bioconjug Chem. 2011;22:1879–1903. doi:10.1021/bc200151q21830812
   PubMed Web of Science ®Google Scholar
• Adura C, Guerrero S, Salas E, et al. Stable conjugates of peptides with gold nanorods for biomedical applications with reduced effects on cell viability. ACS Appl Mater Interfaces. 2013;5:4076–4085. doi:10.1021/am401486h23597259
   PubMedGoogle Scholar
• Olmedo I, Araya E, Sanz F, et al. How changes in the sequence of the peptide CLPFFD-NH 2 can modify the conjugation and stability of gold nanoparticles and their affinity for -amyloid fibrils. Bioconjug Chem. 2008;19:1154–1163. doi:10.1021/bc800016y18510352
   PubMed Web of Science ®Google Scholar
• Cheema MA, Taboada P, Barbosa S, et al. Human serum albumin unfolding pathway upon drug binding: A thermodynamic and spectroscopic description. J Chem Thermodyn. 2009;41:439–447. doi:10.1016/j.jct.2008.11.011
   Web of Science ®Google Scholar
• Lee ES, Youn YS. Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation. J Pharm Investig. 2016;46:305–315. doi:10.1007/s40005-016-0250-3
   Google Scholar
• Bairagi U, Mittal P, Albumin MB. A versatile drug carrier. Austin Ther. 2015;2:1–6.
   Google Scholar
• Cantor JR, Sabatini DM. Cancer cell metabolism: one hallmark, many faces. Cancer Discov. 2013;2:881–898. doi:10.1158/2159-8290.CD-12-0345
   Web of Science ®Google Scholar
• Swiercz R, Mo M, Khare P, et al. Loss of expression of the recycling receptor, FcRn, promotes tumor cell growth by increasing albumin consumption. Oncotarget. 2017;8:3528–3541. doi:10.18632/oncotarget.1386927974681
   PubMedGoogle Scholar
• Commisso C,Davison S, Soydaner-Azeloglu R, et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature. 2013;497:633–637. doi:10.1038/nature1213823665962
   PubMed Web of Science ®Google Scholar
• Merlot AM, Kalinowski DS, Richardson DR. Unraveling the mysteries of serum albumin-more than just a serum protein. Front Physiol. 2014;5:1–7. doi:10.3389/fphys.2014.0026824478714
   PubMedGoogle Scholar
• Nguyen VH, Lee BJ. Protein corona: A new approach for nanomedicine design. Int J Nanomed. 2017;12:3137–3151. doi:10.2147/IJN.S129300
   PubMed Web of Science ®Google Scholar
• Yu Z, Yu M, Zhang Z, Hong G, Xiong Q. Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear. Nanoscale Res Lett. 2014;9:1–7. doi:10.1186/1556-276X-9-34324380376
   PubMedGoogle Scholar
• Bhushan B, Khanadeev V, Khlebtsov B, Khlebtsov N, Gopinath P. Impact of albumin based approaches in nanomedicine: imaging, targeting and drug delivery. Adv Colloid Interface Sci. 2017;246:13–39. doi:10.1016/j.cis.2017.06.01228716187
   PubMed Web of Science ®Google Scholar
• Karimi M, Bahrami S, Ravari SB, et al. Albumin nanostructures as advanced drug delivery systems. Expert Opin Drug Deliv. 2016;13:1609–1623. doi:10.1080/17425247.2016.119314927216915
   PubMed Web of Science ®Google Scholar
• Kratz F. A clinical update of using albumin as a drug vehicle - a commentary. J Control Release. 2014;190:331–336. doi:10.1016/j.jconrel.2014.03.01324637463
   PubMed Web of Science ®Google Scholar
• Kratz F. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release. 2008;132:171–183. doi:10.1016/j.jconrel.2008.05.01018582981
   PubMed Web of Science ®Google Scholar
• Kudarha RR, Sawant KK. Albumin based versatile multifunctional nanocarriers for cancer therapy: fabrication, surface modification, multimodal therapeutics and imaging approaches. Mater Sci Eng C. 2017;81:607–626. doi:10.1016/j.msec.2017.08.004
   PubMed Web of Science ®Google Scholar
• Min Y, Caster JM, Eblan MJ, Wang AZ. Clinical translation of nanomedicine. Chem Rev. 2015;115:11147−11190. doi:10.1021/cr500441926088284
   PubMed Web of Science ®Google Scholar
• Saverot S-E, Reese LM, Cimini D, Vikesland PJ, Bickford LR. Characterization of conventional one-step sodium thiosulfate facilitated gold nanoparticle synthesis. Nanoscale Res Lett. 2015;10:241. doi:10.1186/s11671-015-0940-1
   PubMed Web of Science ®Google Scholar
• Jeremic B, Aguerri AR, Filipovic N. Radiosensitization by gold nanoparticles. Clin Transl Oncol. 2013;15:593–601. doi:10.1007/s12094-013-1034-023359187
   PubMed Web of Science ®Google Scholar
• Pastoriza-Santos I, Liz-Marzan LM. Colloidal silver nanoplates. State of the art and future challenges. J Mater Chem. 2008;18:1724–1737. doi:10.1039/b716538b
   Web of Science ®Google Scholar
• Guerrero AR, Hassan N, Escobar CA, Albericio F, Kogan MJ, Araya E. Gold nanoparticles for photothermally controlled drug release. Nanomedicine (Lond). 2014;9:2023–2039. doi:10.2217/nnm.14.12625343351
   PubMedGoogle Scholar
• Kelly KL, Coronado E, Zhao LL, Schatz GC. The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment. J Phys Chem. 2003;B668–B677. doi:10.1021/jp026731y
   Web of Science ®Google Scholar
• Link S, El-Sayed MA. Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int Rev Phys Chem. 2000;19:409–453. doi:10.1080/01442350050034180
   Web of Science ®Google Scholar
• Link S, El-Sayed MA. Optical properties and ultrafast d ynamics of metallic nanocrystals. Annu Rev Phys Chem. 2003;54:331–366. doi:10.1146/annurev.physchem.54.011002.10375912626731
   PubMed Web of Science ®Google Scholar
• Huang X, El-Sayed MA. Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy. J Adv Res. 2010;1:13–28. doi:10.1016/j.jare.2010.02.002
   Google Scholar
• Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy : challenges, opportunities, and clinical applications. J Control Release. 2015;200:138–157. doi:10.1016/j.jconrel.2014.12.03025545217
   PubMed Web of Science ®Google Scholar
• Vetterlein C, Vasquez R, Bolaños K, et al. Exploring the influence of Diels-Alder linker length on photothermal molecule release from gold nanorods. Colloids Surf B Biointerfaces 2018;166:323–329. doi:10.1016/j.colsurfb.2018.03.021
   Google Scholar
• Alex SA, Chakraborty D, Chandrasekaran N, Mukherjee A. A comprehensive investigation of the differential interaction of human serum albumin with gold nanoparticles based on the variation in morphology and surface functionalization. RSC Adv. 2016;6:52683–52694. doi:10.1039/C6RA10506H
   Web of Science ®Google Scholar
• Bayazitoglu Y, Kheradmand S, Tullius TK. An overview of nanoparticle assisted laser therapy. Int J Heat Mass Transf. 2013;67:469–486. doi:10.1016/j.ijheatmasstransfer.2013.08.018
   Web of Science ®Google Scholar
• Schleich N, Danhier F, Préat V. Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation. J Control Release. 2015;198:35–54. doi:10.1016/j.jconrel.2014.11.02425481448
   PubMed Web of Science ®Google Scholar
• Sahu A, Lee JH, Lee HG, Jeong YY, Tae G. Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy. J Control Release. 2016;236:90–99. doi:10.1016/j.jconrel.2016.06.03127349352
   PubMed Web of Science ®Google Scholar
• Qiu Y, Liu Y, Wang L, et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials. 2010;31:7606–7619. doi:10.1016/j.biomaterials.2010.01.04220656344
   PubMed Web of Science ®Google Scholar
• Prades R, Guerrero S, Araya E, et al. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials. 2012;33:7194–7205. doi:10.1016/j.biomaterials.2012.06.06322795856
   PubMed Web of Science ®Google Scholar
• Kogan MJ, Bastus NG, Amigo R, et al. Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett. 2006;6:110–115. doi:10.1021/nl052110f16402797
   PubMed Web of Science ®Google Scholar
• Stone J, Jackson S, Wright D. Biological applications of gold nanorods. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3:100–109. doi:10.1002/wnan.12020967876
   PubMed Web of Science ®Google Scholar
• Ajnai G, Chiu A, Kan T, Cheng C-C, Tsai T-H, Chang J. Trends of gold nanoparticle-based drug delivery system in cancer therapy. J Exp Clin Med. 2014;6:172–178. doi:10.1016/j.jecm.2014.10.015
   Google Scholar
• Velasco-Aguirre C, Morales F, Gallardo-Toledo E, et al. Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches. Int J Nanomed. 2015;10:4919–4936.
   PubMed Web of Science ®Google Scholar
• Walkey CD, Olsen JB, Guo H, Emili A, Chan WCW. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc. 2012;134:2139–2147. doi:10.1021/ja208433822191645
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Aggarwal P, Hall JB, Mcneil SE. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm. 2008;5:487–495. doi:10.1021/mp800032f18510338
   PubMed Web of Science ®Google Scholar
• Xiao W, Gao H. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system. Int J Pharm. 2018;552:328–339. doi:10.1016/j.ijpharm.2018.10.01130308270
   PubMedGoogle Scholar
• Charbgoo F, Nejabat M, Abnous K, et al. Gold nanoparticle should understand protein corona for being a clinical nanomaterial. J Control Release. 2018;272:39–53. doi:10.1016/j.jconrel.2018.01.00229305922
   PubMed Web of Science ®Google Scholar
• Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol. 2004;4:484–488. doi:10.1166/jnn.2003.07715503433
   PubMed Web of Science ®Google Scholar
• Reddy JS, Vobalaboina V. novel delivery systems for drug targeting to the brain. Drugs Future. 2004;29:63–83. doi:10.1358/dof.2004.029.01.872585
   Web of Science ®Google Scholar
• Majorek KA, Porebski PJ, Dayal A, et al. Structural and immunologic characterization of bovine, horse, and rabbit serum albumins. Mol Immunol 2012;52(3-4):174-82. doi:10.1016/j.molimm.2012.05.011
   Google Scholar
• Bhatty RS. Albumin proteins of eight edible grain legume species: electrophoretic patterns and amino acid composition. J Agric Food Chem. 1982;30:620–622. doi:10.1021/jf00111a0577096818
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 2012;157:168–182. doi:10.1016/j.jconrel.2011.07.03121839127
   PubMed Web of Science ®Google Scholar
• Majorek KA, Porebski PJ, Dayal A, Zimmerman MD, Jablonska K, Stewart AJ, Chruszcz M, Minor W. PDB ID: 3V03. Mol Immunol 52, 174–182 (2012).
   Google Scholar
• Lv L, Chi Y, Chen C, Xu W. Structural and functional properties of ovalbumin glycated by dry-heating in the presence of maltodextrin. Int J Food Prop. 2015;18:1326–1333. doi:10.1080/10942912.2011.620204
   Web of Science ®Google Scholar
• Wang Y, Yu H, Shi X, Luo Z, Lin D, Huang M. PDB ID: 4K2C. J Biol Chem 288, 15980–15987 (2013).
   Google Scholar
• Binaymotlagh R, Hadadzadeh H, Farrokhpour H, et al. In situ generation of the gold nanoparticles-bovine serum albumin (AuNPs-BSA) bioconjugated system using pulsed-laser ablation (PLA). Mater Chem Phys. 2016;177:360–370.
   Google Scholar
• Apadopoulou ATP, Reen REJG, Razier RIAF. Interaction of flavonoids with bovine serum albumin : a fluorescence quenching study. Agric Food Chem. 2005;53:158–163. doi:10.1021/jf048693g
   PubMed Web of Science ®Google Scholar
• Nosrati H, Salehiabar M, Manjili HK, Danafar H, Davaran S. Preparation of magnetic albumin nanoparticles via a simple and one-pot desolvation and co-precipitation method for medical and pharmaceutical applications. Int J Biol Macromol. 2018;108:909–915. doi:10.1016/j.ijbiomac.2017.10.18029101048
   PubMed Web of Science ®Google Scholar
• Peters TJ. All About Albumin. San Diego: Academic Press; 1995.
   Google Scholar
• Pragna Lakshmi T, Mondal M, Ramadas K, Natarajan S. Molecular interaction of 2,4-diacetylphloroglucinol (DAPG) with human serum albumin (HSA): the spectroscopic, calorimetric and computational investigation. Spectrochim Acta A Mol Biomol Spectrosc. 2017;183:90–102. doi:10.1016/j.saa.2017.04.01228441541
   PubMedGoogle Scholar
• Li C, Xing L, Che S. Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery. Dalt Trans. 2012;41:3714. doi:10.1039/c2dt30226h
   PubMed Web of Science ®Google Scholar
• Mariam J, Sivakami S, Dongre PM. Albumin corona on nanoparticles – a strategic approach in drug delivery. Drug Deliv. 2015;1–9. doi:10.3109/10717544.2015.1048488
   Web of Science ®Google Scholar
• Zhiya MA, Xia H, Liu Y, Liu B, Chen W, Zhao Y. Applications of gold nanorods in biomedical imaging and related fields. Chin Sci Bull. 2013;58:2530–2536. doi:10.1007/s11434-013-5720-7
   Google Scholar
• Tarhini M, Greige-Gerges H, Elaissari A. Protein-based nanoparticles: from preparation to encapsulation of active molecules. Int J Pharm. 2017;522:172–197. doi:10.1016/j.ijpharm.2017.01.06728188876
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941–951. doi:10.1038/nbt.333026348965
   PubMed Web of Science ®Google Scholar
• Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small. 2011;7(10):1322–1337. doi:10.1002/smll.20110000121520409
   PubMed Web of Science ®Google Scholar
• Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Toxicity of nanoparticles gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;3:325–327. doi:10.1002/smll.200400093
   Google Scholar
• Hussain I, Nichols RJ, Schiffrin DJ, Brust M, Fernig DG. Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J Nanosci Nanotechnol. 2004;126:10076–10084.
   Google Scholar
• Liu Y, Shipton MK, Ryan J, Kaufman ED, Franzen S, Feldheim DL. Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide - poly (ethylene glycol) monolayers. Anal Chem. 2007;79:2221–2229. doi:10.1021/ac061578f17288407
   PubMed Web of Science ®Google Scholar
• Pissuwan D, Cortie CH, Valenzuela SM, Cortie MB. Gold nanosphere-antibody conjugates for hyperthermal therapeutic applications. Gold Bull. 2007;40:121–129. doi:10.1007/BF03215568
   Web of Science ®Google Scholar
• Mocan L, Matea C, Tabaran FA, et al. Selective ex vivo photothermal nano-therapy of solid liver tumors mediated by albumin conjugated gold nanoparticles. Biomaterials. 2017;119:33–42. doi:10.1016/j.biomaterials.2016.12.00927992805
   PubMedGoogle Scholar
• Murawala P, Tirmale A, Shiras A, Prasad BLV. In situ synthesized BSA capped gold nanoparticles : effective carrier of anticancer drug Methotrexate to MCF-7 breast cancer cells. Mater Sci Eng C. 2014;34:158–167. doi:10.1016/j.msec.2013.09.004
   PubMed Web of Science ®Google Scholar
• Larsen MT, Kuhlmann M, Hvam ML, Howard KA. Albumin-based drug delivery: harnessing nature to cure disease. Mol Cell Ther. 2016;4:3. doi:10.1186/s40591-016-0048-826925240
   PubMedGoogle Scholar
• Brekken RA, Sage EH, Brekken RA. Mini review SPARC, a matricellular protein: at the crossroads of cell matrix SPARC, a matricellular protein : at the crossroads of cell matrix communication. Matrix Biol. 2001;19:815–827.
   Web of Science ®Google Scholar
• Kouros M. SPARC (osteonectin/BM-40). Int J Biochem Cell Biol. 1999;31:1363–1366. doi:10.1016/S1357-2725(99)00090-410641790
   PubMedGoogle Scholar
• Podhajcer OL, Benedetti LG, Girotti MR, Prada F, Salvatierra E, Llera AS. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev. 2008;27:53. doi:10.1007/s10555-008-9146-7
   Google Scholar
• Maeda H. The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci. 2013;104:779–789. doi:10.1111/cas.1215223495730
   PubMed Web of Science ®Google Scholar
• Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006;11:812–818. doi:10.1016/j.drudis.2006.07.00516935749
   PubMed Web of Science ®Google Scholar
• Yuan F, Dellian M, Fukumura D, et al. Vascular permeability in a human tumor xenograft : molecular size dependence and cutoff size advances in brief vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995;55:3752–3756.7641188
   PubMed Web of Science ®Google Scholar
• Grobmyer SR, Moudgil B. What is cancer nanotechnology? Methods Mol Biol. 2010;624:1–9. doi:10.1007/978-1-60761-609-2_120217585
   PubMedGoogle Scholar
• Bhamidipati M, Fabris L. Multiparametric assessment of gold nanoparticle cytotoxicity in cancerous and healthy cells: the role of size, shape, and surface chemistry. Bioconjug Chem. 2016;28:449–460. doi:10.1021/acs.bioconjchem.6b00627
   Web of Science ®Google Scholar
• Sanchez-Iglesias A, Grzelczak M, Altantzis T, et al. Hydrophobic interactions modulate self-assembly of nanoparticles. ACS Nano. 2012;6:11059–11065. doi:10.1021/nn304760523186074
   PubMedGoogle Scholar
• Ahmad R, Fu J, He N, Li S. Advanced gold nanomaterials for photothermal therapy of cancer. J Nanosci Nanotechnol. 2016;16:67–80. doi:10.1166/jnn.2016.1077027398434
   PubMed Web of Science ®Google Scholar
• Elzoghby AO, Hemasa AL, Freag MS. Hybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imaging. J Control Release. 2016;243:303–322. doi:10.1016/j.jconrel.2016.10.02327794493
   PubMed Web of Science ®Google Scholar
• Pramanik S, Banerjee P, Sarkar A, Bhattacharya SC. Size-dependent interaction of gold nanoparticles with transport protein: a spectroscopic study. J Lumin. 2008;128:1969–1974. doi:10.1016/j.jlumin.2008.06.008
   Web of Science ®Google Scholar
• Boulos SP, Davis TA, Yang JA, et al. Nanoparticle − protein interactions: a thermodynamic and kinetic study of the adsorption of bovine serum albumin to gold nanoparticle surfaces. Langmuir. 2013;29(48):14984–14996. doi:10.1021/la402920f24215427
   PubMed Web of Science ®Google Scholar
• Rafaela G-Á, Marilena H, Ana S-I, Luis -ML-M, Kostas K. In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape. Nanoscale. 2018;10:1256–1264. doi:10.1039/C7NR08322J29292433
   PubMedGoogle Scholar
• Chakraborty S, Joshi P, Shanker V, et al. Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. Langmuir. 2011;27(12):7722–7731. doi:10.1021/la200787t21591651
   PubMed Web of Science ®Google Scholar
• Moustaoui H, Saber J, Djeddi I, et al. A protein corona study by scattering correlation spectroscopy: a comparative study between spherical and urchin-shaped gold nanoparticles. Nanoscale. 2019;11:3665–3673. doi:10.1039/C8NR09891C30741295
   PubMedGoogle Scholar
• Online VA, Chandrasekaran N, Mukherjee A. A comprehensive investigation of the differential interaction of Human Serum Albumin with Gold nanoparticles based on the variation in morphology and surface functionalization. RSC Adv. 2016;58:52683–52694.
   Google Scholar
• Carnovale C, Bryant G. Impact of nanogold morphology on interactions with human serum. Phys Chem Phys. 2018;30:29558–29565. doi:10.1039/C8CP05938A
   Google Scholar
• Maleki MS, Moradi O, Tahmasebi S. Adsorption of albumin by gold nanoparticles: equilibrium and thermodynamics studies. Arab J Chem. 2017;10:S491–S502. doi:10.1016/j.arabjc.2012.10.009
   Web of Science ®Google Scholar
• Liu M. pH-sensitive Au – BSA – DOX – FA nanocomposites for combined CT imaging and targeted drug delivery. Int J Nanomedicine. 2017;12:2829–2843. doi:10.2147/IJN.S12827028435261
   PubMedGoogle Scholar
• Elsadek B, Kratz F. Impact of albumin on drug delivery - New applications on the horizon. J Control Release. 2012;157:4–28. doi:10.1016/j.jconrel.2011.09.06921959118
   PubMed Web of Science ®Google Scholar
• Li J, Cai R, Kawazoe N, Chen G. Facile preparation of albumin-stabilized gold nanostars for the targeted photothermal ablation of cancer cells. J Mater Chem B. 2015;3:5806–5814. doi:10.1039/C4TB02051K
   PubMed Web of Science ®Google Scholar
• Loureiro A, Azoia NG, Gomes AC, Cavaco-Paulo A. Albumin-based nanodevices as drug carriers. Curr Pharm Des. 2016;22:1371–1390. doi:10.2174/138161282266616012511490026806342
   PubMed Web of Science ®Google Scholar
• Chen L, Feng W, Zhou X, et al. Facile synthesis of novel albumin-functionalized flower-like MoS 2 nanoparticles for in vitro chemo-photothermal synergistic therapy. RSC Adv. 2016;6:13040–13049. doi:10.1039/C5RA27822H
   Google Scholar
• Lademann J, Richter H, Knorr F, et al. Acta Biomaterialia Triggered release of model drug from AuNP-doped BSA nanocarriers in hair follicles using IRA radiation. Acta Biomater. 2016;30:388–396. doi:10.1016/j.actbio.2015.11.05226621698
   PubMed Web of Science ®Google Scholar
• Peralta DV, He J, Wheeler DA, Zhang JZ, Tarr MA. Encapsulating gold nanomaterials into size-controlled human serum albumin nanoparticles for cancer therapy platforms. J Microencapsul. 2014;31:824–831. doi:10.3109/02652048.2014.94001225090588
   PubMed Web of Science ®Google Scholar
• Zu L, Liu L, Qin Y, Liu H, Yang H. Multifunctional BSA-Au nanostars for photoacoustic imaging and X-ray computed tomography. Nanomed Nanotechnol Biol Med. 2016;12:1805–1813. doi:10.1016/j.nano.2016.05.003
   PubMed Web of Science ®Google Scholar
• Zhang L, Xia K, Bai YY, et al. Synthesis of gold nanorods and their functionalization with bovine serum albumin for optical hyperthermia. J Biomed Nanotechnol. 2014;10:1440–1449.25016644
   PubMed Web of Science ®Google Scholar
• Paraiso WKD, Tanaka H, Sato Y, et al. Preparation of envelope-type lipid nanoparticles containing gold nanorods for photothermal cancer therapy. Colloids Surf B Biointerfaces. 2017;160:715–723. doi:10.1016/j.colsurfb.2017.10.00929035819
   PubMedGoogle Scholar
• Sun J, Guo Y, Xing R, et al. Synergistic in vivo photodynamic and photothermal antitumor therapy based on collagen-gold hybrid hydrogels with inclusion of photosensitive drugs. Colloids Surf A Physicochem Eng Asp. 2017;514:155–160. doi:10.1016/j.colsurfa.2016.11.062
   Web of Science ®Google Scholar
• Liu P, Zheng H, Yang Z, et al. Facile preparation of versatile gadolinium-chelated protein nanocomposite for T1magnetic resonance imaging-guided photodynamic and photothermal synergetic therapy. J Mater Chem. 2018;B 6:1688–1698. doi:10.1039/C8TB00148K
   Web of Science ®Google Scholar
• Sasidharan S, Bahadur D, Srivastava R. Albumin stabilized gold nanostars: A biocompatible nanoplatform for SERS, CT imaging and photothermal therapy of cancer. RSC Adv. 2016;6:84025–84034. doi:10.1039/C6RA11405A
   Web of Science ®Google Scholar
• Liu J, Peng Q. Protein-gold nanoparticle interactions and their possible impact on biomedical applications. Acta Biomater. 2017;55:13–27. doi:10.1016/j.actbio.2017.03.05528377307
   PubMed Web of Science ®Google Scholar
• Rastogi L, Kora AJ, Arunachalam J. Highly stable, protein capped gold nanoparticles as effective drug delivery vehicles for amino-glycosidic antibiotics. Mater Sci Eng C. 2012;32:1571–1577. doi:10.1016/j.msec.2012.04.044
   PubMed Web of Science ®Google Scholar
• Klebowski B, Depciuch J, Parlinska-Wojtan M, Baran J. Applications of noble metal-based nanoparticles in medicine. Int J Mol Sci. 2018;19. doi:10.3390/ijms19124031
   PubMed Web of Science ®Google Scholar
• Li D, Zhang M, Xu F, et al. Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation. Acta Pharm Sin B. 2018;8:74–84. doi:10.1016/j.apsb.2018.04.00629872624
   PubMedGoogle Scholar
• Jokerst JV, Cole AJ, Van de Sompel D, Gambhir SS. Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via raman imaging in living mice. ACS Nano. 2012;6:10366–10377. doi:10.1021/nn304347g23101432
   PubMed Web of Science ®Google Scholar
• Almada M, Leal-Martínez BH, Hassan N, et al. Photothermal conversion ef fi ciency and cytotoxic effect of gold nanorods stabilized with chitosan, alginate and poly (vinyl alcohol). Mater Sci Eng C. 2017;77:583–593. doi:10.1016/j.msec.2017.03.218
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang J, Nie X, et al. Near infrared laser-induced targeted cancer therapy using thermoresponsive polymer encapsulated gold nanorods. J Am Chem Soc. 2014;136:7317–7326. doi:10.1021/ja412735p24773323
   PubMed Web of Science ®Google Scholar
• Encinas-Basurto D, Ibarra J, Juarez J, et al. Hybrid folic acid-conjugated gold nanorods-loaded human serum albumin nanoparticles for simultaneous photothermal and chemotherapeutic therapy. Mater Sci Eng C. 2018;91:669–678. doi:10.1016/j.msec.2018.06.002
   PubMed Web of Science ®Google Scholar
• Pelaz B, Grazu V, Ibarra A, et al. Tailoring the synthesis and heating ability of gold nanoprisms for bioapplications. Langmuir. 2012;28:8965–8970. doi:10.1021/la204712u22260484
   PubMed Web of Science ®Google Scholar
• Bao C, Beziere N, del Pino P, et al. Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers. Small. 2013;9:68–74. doi:10.1002/smll.20120177923001862
   PubMed Web of Science ®Google Scholar
• Cui H-D, Hu D-H, Zhang J-N, et al. Theranostic gold cluster nanoassembly for simultaneous enhanced cancer imaging and photodynamic therapy. Chin Chem Lett. 2017;28:1391–1398. doi:10.1016/j.cclet.2016.12.038
   Web of Science ®Google Scholar
• Santhosh M, Chinnadayyala SR, Singh NK, Goswami P. Human serum albumin-stabilized gold nanoclusters act as an electron transfer bridge supporting specific electrocatalysis of bilirubin useful for biosensing applications. Bioelectrochemistry. 2016;111:7–14. doi:10.1016/j.bioelechem.2016.04.00327126550
   PubMed Web of Science ®Google Scholar
• Ding H, Yang D, Zhao C, et al. Protein-gold hybrid nanocubes for cell imaging and drug delivery. ACS Appl Mater Interfaces. 2015;7:4713–4719. doi:10.1021/am508373325669930
   PubMed Web of Science ®Google Scholar
• Yu X, Liu W, Deng X, Yan S, Su Z. Gold nanocluster embedded bovine serum albumin nanofibers-graphene hybrid membranes for the efficient detection and separation of mercury ion. Chem Eng J. 2018;335:176–184. doi:10.1016/j.cej.2017.10.148
   Web of Science ®Google Scholar
• Ding C, Xu Y, Zhao Y, Zhong H, Luo X. Fabrication of BSA@AuNC-based nanostructures for cell fluoresce imaging and target drug delivery. ACS Appl Mater Interfaces. 2018;10:8947–8954. doi:10.1021/acsami.7b1849329457719
   PubMed Web of Science ®Google Scholar
• Callaghan C, Peralta D, Liu J, et al. Combined treatment of tyrosine kinase inhibitor-labeled gold nanorod encapsulated albumin with laser thermal ablation in a renal cell carcinoma model. J Pharm Sci. 2016;105:284–292. doi:10.1016/j.xphs.2015.11.01726852860
   PubMedGoogle Scholar
• Liu J, Abshire C, Carry C, et al. Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model. BJU Int. 2017;119:342–348. doi:10.1111/bju.2017.119.issue-227431021
   PubMedGoogle Scholar
• Wang Z, Chen L, Chu Z, Huang C, Huang Y, Jia N. Gemcitabine-loaded gold nanospheres mediated by albumin for enhanced anti-tumor activity combining with CT imaging. Mater Sci Eng C. 2018;89:106–118. doi:10.1016/j.msec.2018.03.025
   PubMed Web of Science ®Google Scholar
• Chiu HT, Su CK, Sun YC, Chiang CS, Huang YF. Albumin-gold nanorod nanoplatform for cell-mediated tumoritropic delivery with homogenous chemodrug distribution and enhanced retention ability. Theranostics. 2017;7:3034–3052. doi:10.7150/thno.1927928839462
   PubMed Web of Science ®Google Scholar
• Lademann J, Richter H, Knorr F, et al. Triggered release of model drug from AuNP-doped BSA nanocarriers in hair follicles using IRA radiation. Acta Biomater. 2016;30:388–396. doi:10.1016/j.actbio.2015.11.05226621698
   PubMed Web of Science ®Google Scholar
• Chen J, Sheng Z, Li P, et al. Indocyanine green-loaded gold nanostars for sensitive SERS imaging and subcellular monitoring of photothermal therapy. Nanoscale. 2017;9:11888–11901. doi:10.1039/C7NR02798B28561825
   PubMedGoogle Scholar
• Leopold LF, Tódor IS, Diaconeasa Z, et al. Assessment of PEG and BSA-PEG gold nanoparticles cellular interaction. Colloids Surfaces A Physicochem. Eng Asp. 2017;532:70–76. doi:10.1016/j.colsurfa.2017.06.061
   Web of Science ®Google Scholar
• Baum RP, Kulkarni HR. Theranostics: from molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy - the bad berka experience. Theranostics. 2012;2:437–447. doi:10.7150/thno.364522768024
   PubMed Web of Science ®Google Scholar
• Ganta S, Devalapally H, Shahiwala A, Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 2008;126:187–204. doi:10.1016/j.jconrel.2007.12.01018261822
   PubMed Web of Science ®Google Scholar
• Fernandez-Fernandez A, Manchanda R, McGoron AJ. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol. 2011;165:1628–1651. doi:10.1007/s12010-011-9383-z21947761
   PubMed Web of Science ®Google Scholar
• Fiegel V, Harlepp S, Begin-Colin S, Begin D, Mertz D. Design of protein-coated carbon nanotubes loaded with hydrophobic drugs through sacrificial templating of mesoporous silica shells. Chem Eur J. 2018. doi:10.1002/chem.201705845
   PubMed Web of Science ®Google Scholar
• Fu C, Ding C, Sun X, Fu A. Curcumin nanocapsules stabilized by bovine serum albumin-capped gold nanoclusters (BSA-AuNCs) for drug delivery and theranosis. Mater Sci Eng C. 2018. doi:10.1016/j.msec.2017.12.028
   Web of Science ®Google Scholar
• Chiu HT, Chen CH, Li ML, et al. Bioprosthesis of core-shell gold nanorod/serum albumin nanoimitation: a half-native and half-artificial nanohybrid for cancer theranostics. Chem Mater. 2018;30:729–747. doi:10.1021/acs.chemmater.7b04127
   Web of Science ®Google Scholar
• Quan Q, Xie J, Gao H, et al. HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm. 2011;8:1669–1676. doi:10.1021/mp200125j21838321
   PubMed Web of Science ®Google Scholar
• Abbas M, Zou Q, Li S, Yan X. Self-assembled peptide- and protein-based nanomaterials for antitumor photodynamic and photothermal therapy. Adv Mater. 2017;29. doi:10.1002/adma.201700681
   Web of Science ®Google Scholar
• Khlebtsov B, Prilepskii A, Lomova M, Khlebtsov N. Au-nanocluster-loaded human serum albumin nanoparticles with enhanced cellular uptake for fluorescent imaging. J Innov Opt Health Sci. 2015;9:1650004. doi:10.1142/S1793545816500048
   Web of Science ®Google Scholar
• Han L, Xia J-M, Hai X, Shu Y, Chen X-W, Wang J-H. Protein-stabilized gadolinium oxide-gold nanoclusters hybrid for multimodal imaging and drug delivery. ACS Appl Mater Interfaces. 2017;9:6941–6949. doi:10.1021/acsami.7b0024628177224
   PubMed Web of Science ®Google Scholar
• You Q, Sun Q, Yu M, et al. BSA-bioinspired gadolinium hybrid-functionalized hollow gold nanoshells for NIRF/PA/CT/MR quadmodal diagnostic imaging-guided photothermal/photodynamic cancer therapy. ACS Appl Mater Interfaces. 2017;9:40017–40030. doi:10.1021/acsami.7b1192629087183
   PubMedGoogle Scholar
• Topete A, Alatorre-Meda M, Iglesias P, et al. Fluorescent drug-loaded, polymeric-based, branched gold nanoshells for localized multimodal therapy and imaging of tumoral cells. ACS Nano. 2014;8:2725–2738. doi:10.1021/nn406425h24571629
   PubMed Web of Science ®Google Scholar
• Aaron C, Mitragotri AS. Nanoparticles in the clinic. Bioeng Transl Med. 2016;1:10–29. doi:10.1002/btm2.1000329313004
   PubMedGoogle Scholar
• Ali MRK, Rahman MA, Wu Y, et al. Efficacy, long-term toxicity, and mechanistic studies of gold nanorods photothermal therapy of cancer in xenograft mice. Proc National Acad Sci. 2017;114:E3110–E3118. doi:10.1073/pnas.1619302114
   PubMed Web of Science ®Google Scholar
• Kharlamov AN, Tyurnina AE, Veselova VS, Kovtun OP, Shur VY, Gabinsky JL. Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. Nanoscale. 2015;7:8003–8015. doi:10.1039/C5NR01050K25864858
   PubMedGoogle Scholar